Beijing Tong Ren Tang Chinese Medicine Company Limited
Other OTCTotal Valuation
Beijing Tong Ren Tang Chinese Medicine Company Limited carries a market capitalization of 542.78M, placing it among publicly traded companies globally. Its enterprise value stands at -1.86B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 542.78M |
| Enterprise Value | -1.86B |
Share Statistics
Beijing Tong Ren Tang Chinese Medicine Company Limited currently has 837.10M shares outstanding.
| Shares Outstanding | 837.10M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Beijing Tong Ren Tang Chinese Medicine Company Limited maintains a current ratio of 12.01, meaning it holds 12.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.04, indicating conservative leverage, while an interest coverage ratio of 24,358.19 demonstrates strong ability to service its debt obligations.
| Current Ratio | 12.01 |
| Quick Ratio | 9.37 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.00 |
| Interest Coverage | 24,358.19 |
Financial Efficiency
Beijing Tong Ren Tang Chinese Medicine Company Limited posts a return on equity of 21.94 and a return on invested capital of 20.71.
| Return on Equity (ROE) | 21.94 |
| Return on Assets (ROA) | 19.51 |
| Return on Invested Capital (ROIC) | 20.71 |
| Return on Capital Employed (ROCE) | 20.26 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.50 |
Taxes
Over the trailing twelve months, Beijing Tong Ren Tang Chinese Medicine Company Limited has paid 115.71M in income taxes, reflecting an effective tax rate of 17.16.
| Income Tax | 115.71M |
| Effective Tax Rate | 17.16 |
Stock Price Statistics
Beijing Tong Ren Tang Chinese Medicine Company Limited's stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 0.65, while the 200-day moving average is 0.65.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 0.65 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Beijing Tong Ren Tang Chinese Medicine Company Limited generated 1.40B in revenue and converted that into 540.12M in net income, yielding earnings per share of 0.67. EBITDA reached 657.67M, while operating income came in at 657.67M.
| Revenue | 1.40B |
| Gross Profit | 1.00B |
| Operating Income | 657.67M |
| Pretax Income | 674.21M |
| Net Income | 540.12M |
| EBITDA | 657.67M |
| EBIT | 657.67M |
| Earnings Per Share (EPS) | 0.67 |
Balance Sheet
Beijing Tong Ren Tang Chinese Medicine Company Limited holds 1.97B in cash and equivalents against 1.14M in total debt, resulting in a net debt position of -412.00M. Total book value stands at 2.65B, with working capital of 2.32B providing operational flexibility.
| Cash & Cash Equivalents | 1.97B |
| Total Debt | 1.14M |
| Net Debt | -412.00M |
| Equity (Book Value) | 2.65B |
| Book Value Per Share | 3.17 |
| Working Capital | 2.32B |
Margins
Beijing Tong Ren Tang Chinese Medicine Company Limited operates with a gross margin of 71.66, reflecting its pricing power and cost economics. The operating margin of 46.92 and net profit margin of 38.53 provide insight into operational efficiency.
| Gross Margin | 71.66 |
| Operating Margin | 46.92 |
| Pretax Margin | 48.10 |
| Profit Margin | 38.53 |
| EBITDA Margin | 46.92 |
Scores
Beijing Tong Ren Tang Chinese Medicine Company Limited posts an Altman Z-Score of 3.03, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.03 |